bacterial infections

Vienna-based biotech company, PhagoMed Biopharma, has received more than €4 million in grants and private investments, which will be used to boost the development of alternative therapies to combat antibiotic-resistant bacteria. Read more


The World Health Organisation (WHO) has released its first set of surveillance data on antibiotic resistance, revealing high levels of resistance to several serious bacterial infections globally. Read more


Biotechnology company, Pherecydes Pharma, has raised €8.7 million in a Series B round of funding, which it plans to use to support the production of phages for compassionate use in accordance with good manufacturing practuces (GMP). Read more


Findings published in Nature Communications from nanoengineers at the University of California San Diego, have demonstrated the success of drug delivery by micromotors to treat bacterial infections in the stomach. Read more